期刊文献+

抗体偶联药物的有关进展 被引量:4

The Coupling Methods of Antibody-Immunoconjugated Drugs
原文传递
导出
摘要 化疗肿瘤治疗的常规手段之一,但由于细胞毒药物没有明显的靶向性,导致其副作用十分显著。因此免疫偶联药物由于其良好的靶向性及抗癌活性就成为了研究的热点。文章综述了细胞毒药物与单克隆抗体偶联的各种常用方法,包括使用偶联剂进行偶联、利用肽链进行偶联、利用二硫键进行偶联和利用大分子技术进行偶联,以及抗体偶联药物的研究现状。抗体偶联药物有细胞毒药物、抗体和偶联剂组成,利用各种偶联手段将单克隆抗体与细胞毒药物偶联,不仅可以将细胞毒药物特异性地靶向于肿瘤细胞,而且可以降低细胞毒药物对于正常细胞的杀伤,同时还可以具备缓释、提高药物抗肿瘤活性等效果,是未来肿瘤靶向治疗的发展方向之一。同时文章还结合作者的自身工作,对抗体偶联药物的未来发展方向提出了建议。 Traditional chemotherapy has become one of essential treatments of cancer. However, cymtoxic agents are not tumor specific, which would cause serious side effects. Antibody- Immunoconjugated drugs, also called immunoconjugates, belong to the "targeted chemotherapeutics" category of anti - cancer drugs. Immunoconjugates are composed of three components: including the cytotoxic drug, the monoclonal antibody, and the linker connecting the drug to the antibody. With the special - binding between antibody and antigen expressed on the surface of targeted cancer cells, immunoconjugates provide a method to achieve the excellent localization of drug at the desired Site in the body. This review summarizes the coupling methods of immunoconjugates including the coupling reagents, disulfide linkage, and macromolecular linkage, and the advances of immunoconjugates. In the mean time, it also put forward some advices about the future of immunoconjugates.
作者 王宗凯 刘煜
出处 《药物生物技术》 CAS CSCD 2011年第4期359-363,共5页 Pharmaceutical Biotechnology
基金 国家重大新药创制专项基金资助 项目号:2009ZX09103-654
关键词 单克隆抗体 偶联剂 细胞毒药物 靶向机制 MonocIonal antibody, Coupling reagents, Cytotoxic drug, Targeted mechanism
  • 相关文献

参考文献28

  • 1覃素华,潘君,张兵兵.大分子为载体的抗体偶联药物研究进展[J].中国新药杂志,2004,13(6):488-491. 被引量:5
  • 2董增祥,王清清,宋海峰.治疗性单克隆抗体的研究进展及其免疫偶联物的抗肿瘤应用[J].中国新药杂志,2008,17(15):1286-1290. 被引量:3
  • 3Joshua AH, Theresa MF, Dave WM, etal. Quantitative as sessment of neurite outgrowth in human embryonic stem cell - derived hN2? cells using automated highcontent image analysis[J]. NeuroToxicology, 2010,31(3):277.
  • 4Craig T. A convenient method for synthesis of glyeonanoparti cles for eolorimetrie measuring carbohydrate - protein inter actions[J]. Biochemical and Biophysical Research Communications, 2009,389(1) :22.
  • 5Ma L J, Zhang WZ. Hydrophilic modification of polyethersul lone porous membranes via a thermal - induced surface erosslinking approach [J]. Applied Surface Science, 2009, 255(16) : 7273.
  • 6Emmanuel B, Nicolas J, Mathieu P. Protein Chemical Modifi- cation on Endogenous Amino Acids [J]. Chemistry & Biology, 2010,17(3):213.
  • 7Peter DS. Potent antibody drug conjugates for cancer therapy [J]. Current Opinion in Chemical Biology, 2009,13(3) :235.
  • 8Martin CG. Targeted drug conjugates: principles and progress [J]. Advanced Drug Delivery Reviews, 2001,53(2):171.
  • 9Greg TH. Heterohifunctional Crosslinkers [M]. Bioconjugate Techniques (Second Edition), 2008,276.
  • 10Divya P, Melissa M, Nouri N. Opportunities in discovery and delivery of anticancer drugs targeting rnitochondria and cancer cell metalsolism [J]. Advanced Drug Delivery Reviews,2009,61(14):1250.

二级参考文献42

共引文献19

同被引文献103

  • 1闫雪霏,杨晔,尹登科.两亲性多糖自组装胶束给药系统研究进展[J].中国生化药物杂志,2014,34(4):174-178. 被引量:5
  • 2詹金彪,郑树.天然蛋白毒素的研究和临床应用展望[J].浙江大学学报(医学版),2005,34(3):197-200. 被引量:2
  • 3甄永苏.抗体药物与肿瘤靶向治疗[J].医学研究杂志,2007,36(2):1-2. 被引量:17
  • 4郭怡,蔡常洁.CTLA4Ig诱导免疫耐受作用的研究进展[J].国际内科学杂志,2007,34(7):427-431. 被引量:3
  • 5S. You,J. Zuber,C. Kuhn,M. Baas,F. Valette,V. Sauvaget,S. Sarnacki,B. Sawitzki,J.‐F. Bach,H.‐D. Volk,L. Chatenoud.Induction of Allograft Tolerance by Monoclonal CD3 Antibodies: A Matter of Timing[J].American Journal of Transplantation.2012(11)
  • 6Serengulam V Govindan,David M Goldenberg.Designing immunoconjugates for cancer therapy[J].Expert Opinion on Biological Therapy.2012(7)
  • 7Kamal S. Saini,Hatem A. Azim Jr,Otto Metzger-Filho,Sherene Loi,Christos Sotiriou,Evandro de Azambuja,Martine Piccart.Beyond trastuzumab: New treatment options for HER2-positive breast cancer[J].The Breast.2011
  • 8Jaideep Shenoi,Ajay K Gopal,Oliver W Press,John M Pagel.Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantation[J].Current Opinion in Oncology.2010(2)
  • 9Greg M. Thurber,Michael M. Schmidt,K. Dane Wittrup.Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance[J].Advanced Drug Delivery Reviews.2008(12)
  • 10Sergio Amadori.Monoclonal antibodies and immunoconjugates in acute myeloid leukemia[J].Best Practice & Research Clinical Haematology.2006(4)

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部